Skip to main content
    F

    Fortress Biotech Inc (FBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.71
    -0.17 (-9.04%)

    Market Cap: $62.70M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Fortress Biotech Inc (FBIO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Fortress Biotech (FBIO) to earn $2.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $78.79M. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.00.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus turns from a profit to a loss and revenue estimates rise 43.7%.

    Fiscal year ending Dec 31, 2026
    $2.55
    EPS consensus, revenue $78.79M
    Fiscal year ending Dec 31, 2027
    -$1.00
    EPS consensus, revenue $113.25M
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.55$2.55 to $2.551$78.79M$78.79M to $78.79M1
    Dec 31, 2027-$1.00-$1.00 to -$1.001$113.25M$113.25M to $113.25M1

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.26N/A3$22.91M$22.01M to $23.59M3

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.2% from $2.40.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.55$2.40$2.40$2.40$2.40+6.2%
    Fiscal year ending Dec 31, 2027-$1.00-$0.50-$0.50$0.51$0.51N/A

    Frequently Asked Questions About FBIO

    What is the FBIO stock forecast?

    Consensus analyst estimates put Fortress Biotech's EPS at $2.55 for the fiscal year ending Dec 31, 2026, on revenue of $78.79M.

    What EPS do analysts expect from FBIO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.55, with estimates from $2.55 to $2.55 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.00, with estimates from -$1.00 to -$1.00 from 1 analyst.

    What revenue do analysts expect from Fortress Biotech next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $78.79M, with estimates from $78.79M to $78.79M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $113.25M, with estimates from $113.25M to $113.25M.

    How many analysts cover FBIO?

    1 analyst estimates EPS for Fortress Biotech for the fiscal year ending Dec 31, 2026.